Cite

HARVARD Citation

    Silva Blas, Y. et al. (2021). Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage. Stroke. 52 (1), p. . [Online]. 
  
Back to record